WALACE Study: Western Australian Lowering Acute and Chronic Ear Disease

Project Details

StatusFinished
Effective start/end date1/11/1031/10/11

Funding

  • GlaxoSmithKline: A$3,117.00
  • GlaxoSmithKline: A$14,002.00